Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Ophthalmology

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    March 2017
  1. KEEL S, Xie J, Foreman J, van Wijngaarden P, et al
    The Prevalence of Diabetic Retinopathy in Australian Adults with Self-Reported Diabetes: The National Eye Health Survey.
    Ophthalmology. 2017 Mar 15. pii: S0161-6420(16)32256.
    PubMed     Text format     Abstract available


  2. IP MS, Zhang J, Ehrlich JS
    The Clinical Importance of Changes in Diabetic Retinopathy Severity Score.
    Ophthalmology. 2017 Mar 8. pii: S0161-6420(16)31292.
    PubMed     Text format     Abstract available


  3. SINGH RP, Lehmann R, Martel J, Jong K, et al
    Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.
    Ophthalmology. 2017 Mar 4. pii: S0161-6420(16)31411.
    PubMed     Text format     Abstract available


  4. TORNAMBE P
    Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: Two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1358).
    Ophthalmology. 2017;124:e25-e26.
    PubMed     Text format    


    February 2017
  5. BRESSLER SB, Beaulieu WT, Glassman AR, Gross JG, et al
    Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Ophthalmology. 2017 Feb 1. pii: S0161-6420(16)31179.
    PubMed     Text format     Abstract available


    January 2017
  6. WYKOFF CC, Chakravarthy U, Campochiaro PA, Bailey C, et al
    Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.
    Ophthalmology. 2017 Jan 9. pii: S0161-6420(16)31433.
    PubMed     Text format     Abstract available


  7. SHANMUGAM MP, Harshey KB, Ramanjulu R, Mishra DK, et al
    Re: Wells et al.: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1359).
    Ophthalmology. 2017;124:e5.
    PubMed     Text format    


  8. AZAD S, Takkar B
    Re: Sadiq et al.: Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study (Ophthalmology 2016;123:324-329).
    Ophthalmology. 2017;124:e12-e13.
    PubMed     Text format    


    December 2016
  9. CHONG YH, Fan Q, Tham YC, Gan A, et al
    Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy.
    Ophthalmology. 2016 Dec 27. pii: S0161-6420(16)30930.
    PubMed     Text format     Abstract available


  10. TUFAIL A, Rudisill C, Egan C, Kapetanakis VV, et al
    Automated Diabetic Retinopathy Image Assessment Software: Diagnostic Accuracy and Cost-Effectiveness Compared with Human Graders.
    Ophthalmology. 2016 Dec 23. pii: S0161-6420(16)32018.
    PubMed     Text format     Abstract available


  11. SHARMA S, Kwan S, Fallano KA, Wang J, et al
    Comparison of Visual Outcomes of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients with and without Diabetes Mellitus.
    Ophthalmology. 2016 Dec 22. pii: S0161-6420(16)31490.
    PubMed     Text format     Abstract available


  12. HE J, Xu X, Zhu J, Zhu B, et al
    Lens Power, Axial Length-to-Corneal Radius Ratio, and Association with Diabetic Retinopathy in the Adult Population with Type 2 Diabetes.
    Ophthalmology. 2016 Dec 16. pii: S0161-6420(16)31879.
    PubMed     Text format     Abstract available


  13. CHOUDHRY N, Golding J, Rao RC
    Vitreous Invasion: Neovascular Frond in Proliferative Diabetic Retinopathy.
    Ophthalmology. 2016;123:2625.
    PubMed     Text format    


    November 2016
  14. WANG SY, Andrews CA, Herman WH, Gardner TW, et al
    Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.
    Ophthalmology. 2016 Nov 30. pii: S0161-6420(16)30997.
    PubMed     Text format     Abstract available


  15. SAMARA WA, Shahlaee A, Adam MK, Khan MA, et al
    Quantification of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography and Its Relationship with Visual Acuity.
    Ophthalmology. 2016 Nov 22. pii: S0161-6420(16)31634.
    PubMed     Text format     Abstract available


  16. PAYNE JF, Wykoff CC, Clark WL, Bruce BB, et al
    Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.
    Ophthalmology. 2016 Nov 8. pii: S0161-6420(16)31353.
    PubMed     Text format     Abstract available


    October 2016
  17. NGUYEN HV, Tan GS, Tapp RJ, Mital S, et al
    Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Ophthalmology. 2016 Oct 7. pii: S0161-6420(16)30975.
    PubMed     Text format     Abstract available


  18. FINE SL, Goldberg MF, Tasman W
    Historical Perspectives on the Management of Macular Degeneration, Diabetic Retinopathy, and Retinal Detachment: Personal Reminiscences.
    Ophthalmology. 2016;123.
    PubMed     Text format     Abstract available


  19. SEPAH YJ, Sadiq MA, Boyer D, Callanan D, et al
    Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study.
    Ophthalmology. 2016 Oct 1. pii: S0161-6420(16)31070.
    PubMed     Text format     Abstract available


    September 2016
  20. HEIER JS, Korobelnik JF, Brown DM, Schmidt-Erfurth U, et al
    Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
    Ophthalmology. 2016 Sep 17. pii: S0161-6420(16)30738.
    PubMed     Text format     Abstract available


  21. FERRIS FL 3RD, Nathan DM
    Preventing Diabetic Retinopathy Progression.
    Ophthalmology. 2016;123:1840-2.
    PubMed     Text format    


    August 2016
  22. BALARATNASINGAM C, Inoue M, Ahn S, McCann J, et al
    Visual Acuity Is Correlated with the Area of the Foveal Avascular Zone in Diabetic Retinopathy and Retinal Vein Occlusion.
    Ophthalmology. 2016 Aug 11. pii: S0161-6420(16)30657.
    PubMed     Text format     Abstract available


    July 2016
  23. LIN J, Chang JS, Smiddy WE
    Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
    Ophthalmology. 2016 Jul 14. pii: S0161-6420(16)30404.
    PubMed     Text format     Abstract available


  24. BURGESS PI, Harding SP, Garcia-Finana M, Beare NA, et al
    First Prospective Cohort Study of Diabetic Retinopathy from Sub-Saharan Africa: High Incidence and Progression of Retinopathy and Relationship to Human Immunodeficiency Virus Infection.
    Ophthalmology. 2016 Jul 9. pii: S0161-6420(16)30409.
    PubMed     Text format     Abstract available


    May 2016
  25. CAMPOCHIARO PA, Khanani A, Singer M, Patel S, et al
    Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression.
    Ophthalmology. 2016 May 25. pii: S0161-6420(16)30201.
    PubMed     Text format     Abstract available


  26. SINGH RP, Habbu K, Ehlers JP, Lansang MC, et al
    The Impact of Systemic Factors on Clinical Response to Ranibizumab for Diabetic Macular Edema.
    Ophthalmology. 2016 May 24. pii: S0161-6420(16)30084.
    PubMed     Text format     Abstract available


  27. WYKOFF C, Elman MJ, Regillo C, Ding B, et al
    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials.
    Ophthalmology. 2016 May 18. pii: S0161-6420(16)30097.
    PubMed     Text format     Abstract available


    April 2016
  28. HALL J
    Re: Das et al.: Diabetic macular edema: pathophysiology and novel therapeutic targets (Ophthalmology 2015;122:1375-94).
    Ophthalmology. 2016;123:e26-7.
    PubMed     Text format    


    March 2016
  29. PIERAMICI DJ, Wang PW, Ding B, Gune S, et al
    Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.
    Ophthalmology. 2016 Mar 15. pii: S0161-6420(16)00168.
    PubMed     Text format     Abstract available


  30. SILVA PS, Horton MB, Clary D, Lewis DG, et al
    Identification of Diabetic Retinopathy and Ungradable Image Rate with Ultrawide Field Imaging in a National Teleophthalmology Program.
    Ophthalmology. 2016 Mar 1. pii: S0161-6420(16)00149.
    PubMed     Text format     Abstract available


    February 2016
  31. WELLS JA, Glassman AR, Ayala AR, Jampol LM, et al
    Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
    Ophthalmology. 2016 Feb 27. pii: S0161-6420(16)00206.
    PubMed     Text format     Abstract available


  32. WILEY HE, Thompson DJ, Bailey C, Chew EY, et al
    A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.
    Ophthalmology. 2016 Feb 10. pii: S0161-6420(15)01410.
    PubMed     Text format     Abstract available


  33. SHUKLA D
    Re: Sophie et al.: Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab (Ophthalmology 2015;122:1395-401).
    Ophthalmology. 2016;123:e11-2.
    PubMed     Text format    


  34. SOPHIE R, Lu N, Campochiaro PA
    Reply.
    Ophthalmology. 2016;123:e12-3.
    PubMed     Text format    


    January 2016
  35. DO DV, Nguyen QD, Vitti R, Berliner AJ, et al
    Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
    Ophthalmology. 2016 Jan 28. pii: S0161-6420(15)01354.
    PubMed     Text format     Abstract available


  36. SODHI A, Montaner S
    Re: Kwon et al.: Aqueous levels of angiopoietin-like 4 and semaphorin 3E correlate with nonperfusion area and macular volume in diabetic retinopathy (Ophthalmology 2015;122:968-75).
    Ophthalmology. 2016;123:e7-8.
    PubMed     Text format    


  37. KWON SH, Shin JP, Kim IT, Park DH, et al
    Reply.
    Ophthalmology. 2016;123:e8.
    PubMed     Text format    


    October 2015
  38. SADIQ MA, Soliman MK, Sarwar S, Agarwal A, et al
    Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study.
    Ophthalmology. 2015 Oct 28. pii: S0161-6420(15)01110.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: